[go: up one dir, main page]

WO1993009778A3 - Utilisation de brl 38227 pour le traitement et la prophylaxie de l'hyperlipidemie - Google Patents

Utilisation de brl 38227 pour le traitement et la prophylaxie de l'hyperlipidemie Download PDF

Info

Publication number
WO1993009778A3
WO1993009778A3 PCT/GB1992/002141 GB9202141W WO9309778A3 WO 1993009778 A3 WO1993009778 A3 WO 1993009778A3 GB 9202141 W GB9202141 W GB 9202141W WO 9309778 A3 WO9309778 A3 WO 9309778A3
Authority
WO
WIPO (PCT)
Prior art keywords
prophylaxis
treatment
hyperlipidemia
brl
mammals
Prior art date
Application number
PCT/GB1992/002141
Other languages
English (en)
Other versions
WO1993009778A2 (fr
Inventor
Thomas Conway Hamilton
Timothy Charles Gadsden Tasker
David Robert Howlett
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of WO1993009778A2 publication Critical patent/WO1993009778A2/fr
Publication of WO1993009778A3 publication Critical patent/WO1993009778A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procédé de traitement et/ou de prophylaxie de l'hyperlipidémie chez les mammifières, dans lequel on administre au mammifère nécessitant ce type de traitement et/ou de prophylaxie, une quantité efficace et/ou prophylactique de BRL 38227.
PCT/GB1992/002141 1991-11-21 1992-11-19 Utilisation de brl 38227 pour le traitement et la prophylaxie de l'hyperlipidemie WO1993009778A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9124754.4 1991-11-21
GB919124754A GB9124754D0 (en) 1991-11-21 1991-11-21 Pharmaceuticals

Publications (2)

Publication Number Publication Date
WO1993009778A2 WO1993009778A2 (fr) 1993-05-27
WO1993009778A3 true WO1993009778A3 (fr) 1993-07-22

Family

ID=10705002

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1992/002141 WO1993009778A2 (fr) 1991-11-21 1992-11-19 Utilisation de brl 38227 pour le traitement et la prophylaxie de l'hyperlipidemie

Country Status (3)

Country Link
AU (1) AU2949592A (fr)
GB (1) GB9124754D0 (fr)
WO (1) WO1993009778A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323745A2 (fr) * 1988-01-06 1989-07-12 Beecham Group Plc Préparations pharmaceutiques
WO1991008741A1 (fr) * 1989-12-11 1991-06-27 Beecham Group Plc Utilisation de cromakalim/brl 38227 pour le traitement de l'hyperreactivite des voies respiratoires

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323745A2 (fr) * 1988-01-06 1989-07-12 Beecham Group Plc Préparations pharmaceutiques
WO1991008741A1 (fr) * 1989-12-11 1991-06-27 Beecham Group Plc Utilisation de cromakalim/brl 38227 pour le traitement de l'hyperreactivite des voies respiratoires

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE JOURNAL OF LABORATORY AND CLINICAL MEDICINE vol. 114, no. 6, December 1989, pages 646 - 654 FRANK W. ROCKHOLD ET AL 'BENEFICIAL EFFECTS OF PINACIDIL ON BLOOD LIPIDS: COMPARISONS WITH PRAZOSIN AND PLACEBO IN PATIENTS WITH HYPERTENSION' *

Also Published As

Publication number Publication date
AU2949592A (en) 1993-06-15
GB9124754D0 (en) 1992-01-15
WO1993009778A2 (fr) 1993-05-27

Similar Documents

Publication Publication Date Title
AU3409293A (en) Method and composition for treating immune disorders, inflammation and chronic infections
BG102668A (en) Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x
EP0717592A4 (fr) Procede et composition de traitement du syndrome d'apathie-amotivation
AU7936194A (en) A composition for preventing and treating kinetotia syndrome
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
EP0640097A4 (fr) Compositions et procedes de vaccination contre les coronavirus.
AU5852794A (en) Sterilization devices, sporidical compositions, sterilization methods, and devices for reducing surface tension
GB2285925B (en) Novel attenuated pseudomonas aeruginosa strains
EP0591303A4 (en) Methods and compositions for treating malaria and other diseases
AU6946594A (en) Methods for the treatment and prevention of diarrhea
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU8634291A (en) Process and device for the manufacture of high-pressure laminates
GR3021203T3 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane.
AU2194792A (en) Fuel oil treatment
GB2271509B (en) Antivenom immunesera
WO1993024117A3 (fr) Medicaments pour le traitement de l'anxiete
AU7596994A (en) Methods and compositions for retarding the aging process
WO1993009778A3 (fr) Utilisation de brl 38227 pour le traitement et la prophylaxie de l'hyperlipidemie
EP0725647A4 (fr) Utilisation de lectines pour la contraception, la prophylaxie et la therapie
AU7994891A (en) Use of cromakalim/brl 38227 for the treatment of hyperreactivity of airways
WO1995003798A3 (fr) UTILISATION D'AGONISTES D'α-2 A EFFICACITE CENTRALE POUR INHIBER LE METABOLISME DE POSTAGRESSION
AU6953094A (en) Methods and compositions for treating depression and other psychiatric disorders
AU6276494A (en) Method for treating colic and constipation
AU6060694A (en) Method for treating acquired immune deficiency syndrome
AU8497191A (en) Compositions and methods for treating hiv infections

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase